Furthermore, whereas CD8+ T cells are essential for immune-mediated tumor rejection, given their correlation with patient survival and treatment success, it is crucial to recognize that the collaboration of various immune cells with CD8+ T cells is likely essential for a successful and enduring antitumor immune response [349,350]. Here, CD8A is linked to neoplasm.